Pharming Group (PHAR)
7.53
-0.23
(-2.96%)
USD |
NASDAQ |
Nov 22, 16:00
7.48
-0.05
(-0.66%)
After-Hours: 20:00
Pharming Group Debt to Equity Ratio: 0.4226 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.4226 |
| June 30, 2024 | 0.4095 |
| March 31, 2024 | 0.655 |
| December 31, 2023 | 0.6327 |
| September 30, 2023 | 0.6263 |
| June 30, 2023 | 0.6786 |
| March 31, 2023 | 0.6791 |
| December 31, 2022 | 0.6518 |
| September 30, 2022 | 0.6074 |
| June 30, 2022 | 0.6509 |
| March 31, 2022 | 0.7082 |
| December 31, 2021 | 0.7303 |
| September 30, 2021 | 0.7382 |
| June 30, 2021 | 0.7442 |
| March 31, 2021 | 0.7739 |
| December 31, 2020 | 0.8274 |
| September 30, 2020 | 0.8935 |
| June 30, 2020 | 0.9659 |
| March 31, 2020 | 1.049 |
| December 31, 2019 | 0.4355 |
| September 30, 2019 | 0.5979 |
| June 30, 2019 | 0.7597 |
| March 31, 2019 | 0.9688 |
| December 31, 2018 | 1.174 |
| September 30, 2018 | 1.606 |
| Date | Value |
|---|---|
| June 30, 2018 | 2.042 |
| March 31, 2018 | 2.469 |
| December 31, 2017 | 5.063 |
| September 30, 2017 | 14.12 |
| June 30, 2017 | 13.25 |
| March 31, 2017 | 2.239 |
| December 31, 2016 | 2.422 |
| September 30, 2016 | 0.9533 |
| June 30, 2016 | 0.8213 |
| March 31, 2016 | 0.6846 |
| December 31, 2015 | 0.621 |
| September 30, 2015 | 0.5982 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | -1.475 |
| June 30, 2013 | -10.64 |
| March 31, 2013 | -1.582 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.4095
Minimum
Jun 2024
1.049
Maximum
Mar 2020
0.694
Average
0.6788
Median
Debt to Equity Ratio Benchmarks
| uniQure NV | 0.9157 |
| ProQR Therapeutics NV | 0.1805 |
| Merus NV | 0.00 |
| argenx SE | -- |
| Pharvaris NV | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 425.51M |
| Total Liabilities (Quarterly) | 199.72M |
| Shareholders Equity (Quarterly) | 225.79M |
| Current Ratio | 3.534 |
| Net Debt Paydown Yield | 1.45% |